Clinical Trial Update: Neostigmine and Glycopyrrolate for the Treatment of Headache After Dural Puncture [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating neostigmine with glycopyrrolate for treating post-dural puncture headache is currently recruiting. The study is sponsored by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-dural Puncture Headache

Drugs mentioned

• Glycopyrrolate (glycopyrrolate)
• Neostigmine (neostigmine)

Snippet

Sponsor: Mayo Clinic | Conditions: Post-Dural Puncture Headache | Phase 2 | Status: RECRUITING